HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
2.430
+0.050 (2.10%)
Dec 20, 2024, 4:00 PM EST - Market closed
HeartBeam Market Cap
HeartBeam has a market cap or net worth of $64.80 million as of December 20, 2024. Its market cap has increased by 83.66% in one year.
Market Cap
64.80M
Enterprise Value
59.03M
1-Year Change
83.66%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since the IPO on November 11, 2021, HeartBeam's market cap has increased from $46.53M to $64.80M, an increase of 39.26%. That is a compound annual growth rate of 11.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 64.80M | 4.73% |
| Dec 29, 2023 | 61.87M | 58.40% |
| Dec 30, 2022 | 39.06M | 62.39% |
| Dec 31, 2021 | 24.05M | -48.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Forian | 65.75M |
| Atara Biotherapeutics | 65.66M |
| Galectin Therapeutics | 65.27M |
| Hyperfine | 64.57M |
| BeyondSpring | 64.08M |
| Regencell Bioscience Holdings | 64.02M |
| Cue Biopharma | 63.98M |
| InterCure | 63.75M |